Atlanta, GA – Scibility Media – 10/17/2014.
This article discusses three medical technology/instruments companies: Medical Alarm Concepts Holding, Inc. (OTCPINK: MDHI), OraSure Technologies, Inc. (NASDAQ: OSUR) and Allied Healthcare Products, Inc. (NASDAQ: AHPI)
If the numbers coming out of the medical technology/instruments sector hold up to scrutiny, then investors on Wall Street might be in danger of missing out on the tremendous growth potential taking shape.
Much of this growth potential is being caused by an upheaval at the regulatory and structural level of the sector. A recent report from Ernst and Young cites three main trends: the move toward value-based health care, growing regulatory pressures, and resource constraints within the industry itself.
All three indeed suggest a negative wind blowing over the sector but therein lays the rub. Companies that are weathering this perfect storm are on the cusp of delivering perhaps the biggest shift in gain potential and investors who keep their fingers on the pulse stand to gain the most – for obvious reasons.
So what should investors look out for? What are the companies that are leading the field, so to speak?
Medical Alarm Concepts Holding, Inc. (OTCPINK: MDHI) is the creator of the patented MediPendant(R) personal medical alarm device that provides users with a reliable and innovative way to communicate with emergency personnel and loved ones whenever medical assistance is needed. The company has been launching an earnings charge of late, reporting gross margin improvement from 41% in quarter’s end on March 31, 2013 to 79% in quarter’s end on March 31, 2014.
Those numbers more than hint at progress for Medical Alarm Concepts Holding, Inc. (OTCPINK: MDHI) and help to justify the company’s push to seek out “synergistic opportunities for expansion through acquisition.”
The corridor of opportunity has other doors, of course. Doors like OraSure Technologies, Inc. (NASDAQ: OSUR). The company is a leader in the development, manufacture and distribution of point of care diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions.
OraSure Technologies, Inc. (NASDAQ: OSUR) has several products on the market, including rapid tests for HIV. The company recently joined forces with the Healthy Trucking Association of America (HTAA) to launch Truckers Rolling Against Hepatitis C.
Then there is Allied Healthcare Products, Inc. (NASDAQ: AHPI), a company that manufactures, markets, and distributes respiratory care products, medical gas equipment, and emergency medical products globally. The company has hit some turbulence, especially for the quarter ending December 31, 2013. But things are looking up for Allied Healthcare Products, Inc. (NASDAQ: AHPI) and analysts all agree that the specter of Ebola could create strong opportunities of medical device companies all around.
The three mentioned medical technology/instruments companies above are of course just a small sampling of what’s out there. The key is not so much “who” they are, but “what” they do.
EquiPress.com is a non-advertisement based network (currently in limited release) designed for investors to discover and communicate with publicly traded companies in real-time.
Sign-up for free now to experience the full benefits of EquiPress pre-launch.
Discover and communicate with companies you would otherwise never have seen based on your interests, company news, personalized news feeds, and one-on-one communications with no middle-men nor advertisements. Read our no advertisements pledge.
Can’t find your company on EquiPress? Send us an email to email@example.com and we will contact them for you.
Interested in a one month free trial? Get access to our private investor network, real-time news distribution, automatic disclaimers, corporate analytics, verified public profile, and industry-wide marketing of your corporate news.
Disclosure: EquiPress is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. EquiPress does not hold any equity or financial interest in any publicly traded company. EquiPress provides a uniform subscription based service to all publicly traded companies on a monthly basis at a rate of $495 to provide investor awareness. EquiPress receives only cash compensation from clients. Despite the relationship, EquiPress maintains a neutral stance (nonbiased) on any investment related opinions and exists solely for the purpose of allowing investors to communicate with the publicly traded companies in an effort to establish for themselves investment considerations. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor. Please visit www.equipress.com for complete risks and disclosures.